ABL Diagnostics Société anonyme (EPA:ABLD)
2.760
-0.180 (-6.12%)
At close: Nov 10, 2025
EPA:ABLD Revenue
ABL Diagnostics Société anonyme had revenue of 3.28M EUR in the half year ending June 30, 2025, with 13.17% growth. This brings the company's revenue in the last twelve months to 6.23M, up 0.35% year-over-year. In the year 2024, ABL Diagnostics Société anonyme had annual revenue of 5.87M, down -5.16%.
Revenue (ttm)
6.23M
Revenue Growth
+0.35%
P/S Ratio
7.60
Revenue / Employee
327.95K
Employees
19
Market Cap
47.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.87M | -319.28K | -5.16% |
| Dec 31, 2023 | 6.19M | -3.17M | -33.89% |
| Dec 31, 2022 | 9.36M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 1.00 | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |